Suppr超能文献

右美托咪定与丙泊酚在神经重症监护中的比较[DEXPRONE]:一项临床实用性和安全性的多中心回顾性评估。

DEXmedetomidine compared to PROpofol in NEurocritical Care [DEXPRONE]: A multicenter retrospective evaluation of clinical utility and safety.

机构信息

Department of Pharmacy, Yale New Haven Health, 20 York Street, New Haven, CT 06510, United States of America; Clinical Redesign, Yale New Haven Health, 200 Orchard Street, New Haven, CT 06511, United States of America.

Department of Pharmacy, Virginia Commonwealth University Medical Center, 1250 E. Marshall Street, Richmond, VA 23219, United States of America.

出版信息

J Crit Care. 2020 Dec;60:79-83. doi: 10.1016/j.jcrc.2020.07.021. Epub 2020 Jul 24.

Abstract

PURPOSE

Although guidelines recommend dexmedetomidine (DEX) or propofol (PRO) as preferred sedatives in critically ill adults, comparisons in neurocritical care (NCC) are limited. We aimed to evaluate the clinical utility and safety of DEX compared with PRO in NCC setting.

MATERIALS AND METHODS

This retrospective, multicenter, observational cohort study conducted at three tertiary academic hospitals with Level 1 Trauma Center and Comprehensive Stroke Center designations, compared the clinical indication and safety of DEX vs PRO in patients in NCC setting.

RESULTS

179 patients were included (94 DEX and 85 PRO), median age of 58, 49% were male (DEX) and 58% were male (PRO). PRO was more commonly used to manage agitation. DEX was more commonly used for facilitating extubation, alcohol withdrawal, and sedation during frequent neurologic assessments. Mean Glasgow Coma Scale scores were higher in DEX group (11 vs. 9; p = .04). The duration of either infusions, mechanical ventilation, and lengths of stay were similar. No difference was observed in hypotension or bradycardia rates. Death was significantly higher with PRO (DEX 10% vs. PRO 22%; p = .02).

CONCLUSIONS

DEX and PRO were used for distinct indications in our cohort. Adverse effect profiles and clinical outcome, in the cohorts are largely similar.

摘要

目的

尽管指南建议将右美托咪定(DEX)或丙泊酚(PRO)作为危重症成人的首选镇静剂,但在神经重症监护(NCC)中的比较有限。我们旨在评估 DEX 与 PRO 在 NCC 环境中的临床实用性和安全性。

材料和方法

这项回顾性、多中心、观察性队列研究在三家具有 1 级创伤中心和综合卒中中心指定的三级学术医院进行,比较了 DEX 与 PRO 在 NCC 环境中患者的临床适应证和安全性。

结果

共纳入 179 例患者(94 例 DEX 和 85 例 PRO),中位年龄为 58 岁,49%为男性(DEX),58%为男性(PRO)。PRO 更常用于治疗躁动。DEX 更常用于促进拔管、酒精戒断和频繁神经评估时的镇静。DEX 组的格拉斯哥昏迷评分平均值较高(11 分比 9 分;p=0.04)。两种输注、机械通气和住院时间的持续时间相似。低血压或心动过缓的发生率无差异。PRO 的死亡率明显更高(DEX 为 10%,PRO 为 22%;p=0.02)。

结论

在我们的队列中,DEX 和 PRO 用于不同的适应证。两组的不良效应谱和临床结局基本相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验